Clinical Trial

Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid

Recruiting
View on ClinicalTrials.gov →
Summary
The overall goal of the randomized control trial (RCT) will be to evaluate the efficacy of modifications to a web-based tool for patient decision-making regarding return of genomic results that will more closely focus on rare cancers. Participants will be given access to a web-based decision aid (or a standard control) that guides participants in making decisions about what type of genomic results they would like to receive from testing performed in the PE-CGS study (NCT06340646).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-03; most recent amendment 2026-07-21.
Trial Details
NCT Number NCT06910670
Lead Sponsor Washington University School of Medicine
Collaborators: National Cancer Institute (NCI)
Conditions Cholangiocarcinoma, Colorectal Cancer, Multiple Myeloma
Enrollment 240 participants
Start Date 2025-04-03
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-23